Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

Fri, 01st Dec 2023 07:41

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

According to Nationwide, the annual pace of decline in UK house prices eased somewhat in November, as house prices rose on a monthly basis.

"There has been a significant change in market expectations for the future path of bank rate in recent months which, if sustained, could provide much needed support for housing market activity," said Robert Gardner, Nationwide's chief economist.

So far on Friday morning, there have been manufacturing purchasing managers' index readings from China, Ireland and Japan. The economic calendar still has a slew of manufacturing PMI releases, including for the EU, Germany, the UK and the US.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called up 0.3% at 7,478.50

----------

Hang Seng: down 1.0% at 16,869.78

Nikkei 225: closed down 0.2% at 33,431.51

S&P/ASX 200: closed down 0.2% at 7,073.20

----------

DJIA: closed up 520.47 points, 1.5%, at 35,950.89

S&P 500: closed up 17.22 points, or 0.4%, at 4,567.80

Nasdaq Composite: closed down 32.27 points, or 0.2%, at 14,226.22

----------

EUR: up at USD1.0911 (USD1.0909)

GBP: down at USD1.2638 (USD1.2652)

USD: up at JPY148.22 (JPY147.85)

Gold: up at USD2,040.60 per ounce (USD2,038.85)

(Brent): up at USD80.61 a barrel (USD80.56)

(changes since previous London equities close)

----------

ECONOMICS

----------

Friday's key economic events still to come:

08:30 EST Canada labour force survey

09:30 EST Canada manufacturing PMI

10:00 CET EU manufacturing PMI

09:50 CET France manufacturing PMI

09:55 CET Germany manufacturing PMI

09:15 CET Spain manufacturing PMI

09:30 GMT UK manufacturing PMI

09:00 EST US Fed Chicago President Austan Goolsbee speaks

09:45 EST US S&P Global manufacturing PMI

10:00 EST US ISM manufacturing PMI

----------

The annual pace of decline in UK house prices eased somewhat in November, as house prices rose on a monthly basis, according to new data from Nationwide. On a seasonally adjusted basis, UK house prices rose by 0.2% in November from October, with growth slowing slightly from a 0.9% on-month rise in October. On an annual basis, prices were 2.0% lower in November, slowing from the 3.3% fall in October. The average house price, without seasonal adjustment, was GBP258,557 in November, down from GBP259,423 in October.

----------

A rise in new orders pushed China's factory sector back into growth in November, survey results from S&P Global showed. The Caixin manufacturing purchasing managers' index rose to a three-month high of 50.7 points last month from 49.5 in October. The reading above 50 points indicates growth in the sector. The Caixin PMI moved in the opposite direction from the same indicator issued by the National Bureau of Statistics on Thursday. Its manufacturing PMI reading for November was 49.4 points, still in contraction territory and slightly down from 49.5 in October. "Demand continued to grow, as the gauge for new orders remained in expansionary territory for the fourth consecutive month, hitting the highest since June," said Wang Zhe, senior economist at Caixin Insight Group. "Compared with consumer goods and intermediate goods, the supply and demand of investment goods were weaker.

----------

Manufacturing conditions in Japan continued to worsen in November, but performed better than initially indicated. The au Jibun manufacturing PMI fell to 48.3 points in November from 48.7 in October, but outperformed the flash estimate, and FXStreet-cited consensus, which were both at 48.1. Edging away from the 50 point mark separating expansion from contraction, the reading indicates an accelerated contraction in activity.

----------

A two-month decline in factory sector activity in Ireland was arrested in November, though only just barely, amid an improvement in production requirements, according to survey results released by S&P Global. Less positively, export orders declined for the third straight month. The AIB Ireland manufacturing PMI came in at 50.0 points in November, indicating neither growth nor decline. This was up from 48.2 points in October and 49.6 in September and was the second highest reading since February.

----------

BROKER RATING CHANGES

----------

UBS raises Antofagasta to 'buy' (neutral) - price target 1,700 (1,600) pence

----------

UBS raises Anglo American to 'buy' (neutral) - price target 2,500 pence

----------

Deutsche Bank cuts Pearson to 'hold' (buy) - price target 1,050 (1,100) pence

----------

COMPANIES - FTSE 100

----------

AstraZeneca has decided to discontinue the Stabilize-ckd and Dialize-Outcomes Phase III evidence trials for Lokelma, sodium zirconium cyclosilicate. The decision was made due to substantially increased enrolment timelines and low event rates, respectively, which made it prohibitive to deliver study results within a timeframe to meaningfully advance clinical practice. They are part of the Crystalize evidence programme, which researches the benefit of Lokelma in the management of hyperkalaemia across the cardiorenal spectrum.

----------

COMPANIES - FTSE 250

----------

3i Infrastructure said it has completed the sale of its 25% stake in Attero, a waste treatment and recycling companies in the Netherlands. The sale, to Ardian, was announced back in July. 3i will receive EUR215 million for the sale, which will be used to partially repay drawings on the company's revolving credit facility. Also, 3i said it has completed a further investment of GBP30 million in Future Biogas to fund the acquisition of two anaerobic digestion plants which are currently operated by Future Biogas.

----------

OTHER COMPANIES

----------

James Halstead updated shareholders ahead of its annual general meeting Friday. It said that whilst its "major markets face strong competition", it is seeing improved output and profits which are materially ahead of the comparatives. "We are confident of achieving full year market expectations of improved bottom line results and exceeding the half year comparatives, as well as extending our track record of increased dividends," Chair Anthony Wild said. "I and the board remain positive about the medium-term prospects for the group as a whole."

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.